(Q34488798)

2 August 2017

1 reference

title

Trichomoniasis and its treatment (English)

1 reference

2 August 2017

1 reference

Neha Nanda

1

1 reference

2 August 2017

Ross G Michel

series ordinal

2

1 reference

2 August 2017

George Kurdgelashvili

series ordinal

3

1 reference

2 August 2017

Karen A Wendel

series ordinal

4

1 reference

2 August 2017

publication date

1 February 2006

1 reference

Expert Review of Anti-infective Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

125-135

1 reference

Resolution of six chromosomes of Trichomonas vaginalis and conservation of size and number among isolates

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

The double-stranded RNA in Trichomonas vaginalis may originate from virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Double stranded RNA virus in South African Trichomonas vaginalis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis: in vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

A clinical study on the association of Trichomonas vaginalis and Mycoplasma hominis infections in women attending a sexually transmitted disease (STD) outpatient clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Epidemiology of trichomonas vaginalis. A prospective study in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

The epidemiology of trichomoniasis in women in four African cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Aetiology of urethral discharge in Bangui, Central African Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis: Reevaluation of Its Clinical Presentation and Laboratory Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Predictive value of the clinical diagnosis of lower genital tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Aetiology of chronic prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis as a cause of urethritis in Malawian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Urine proves a poor specimen for culture of Trichomonas vaginalis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Improved detection by DNA amplification of Trichomonas vaginalis in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Concentrations of metronidazole and tinidazole in male genital tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Revised UK national guidelines on sexually transmitted infections and closely related conditions 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Single-Dose Oral Treatment of Vaginal Trichomoniasis with Tinidazole and Metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Is metronidazole teratogenic? A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Oral tinidazole treatment during pregnancy and teratogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Trichomoniasis: trends in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Metronidazole hypersensitivity and oral desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

Mycoplasma hominis and Trichomonas vaginalis symbiosis: multiplicity of infection and transmissibility of M. hominis to human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.125

21 January 2018

Identifiers

DOI

10.1586/14787210.4.1.125

1 reference

2 August 2017

1 reference